Certified Pediatric Hematology Oncology Nurse (CPHON) Practice Exam 2025 - Free CPHON Practice Questions and Study Guide

In Dyskeratosis Congenita (DKC), thrombocytopenia is recognized as a characteristic finding. DKC is a genetic disorder marked by defects in the maintenance of telomeres, which can result in various hematological abnormalities, including low platelet counts. The presence of thrombocytopenia in patients with DKC highlights the implications of dysfunctional hematopoiesis associated with the underlying genetic defects.

Recognizing thrombocytopenia as a characteristic finding in DKC emphasizes its relevance in clinical assessments and monitoring of patients. This understanding assists healthcare providers in anticipating the potential complications arising from low platelet counts, such as bleeding tendencies, which require appropriate management and patient education.

While thrombocytopenia is typically observed in DKC, it is not exclusive to this condition nor is it a universal finding in all patients with DKC. Thus, focusing on its characterization within the context of DKC provides valuable insight into the disorder's hematological implications.